Meco, M.; Giustiniano, E.; Nisi, F.; Zulli, P.; Agosteo, E.
MAPK, PI3K/Akt Pathways, and GSK-3β Activity in Severe Acute Heart Failure in Intensive Care Patients: An Updated Review. J. Cardiovasc. Dev. Dis. 2025, 12, 266.
https://doi.org/10.3390/jcdd12070266
AMA Style
Meco M, Giustiniano E, Nisi F, Zulli P, Agosteo E.
MAPK, PI3K/Akt Pathways, and GSK-3β Activity in Severe Acute Heart Failure in Intensive Care Patients: An Updated Review. Journal of Cardiovascular Development and Disease. 2025; 12(7):266.
https://doi.org/10.3390/jcdd12070266
Chicago/Turabian Style
Meco, Massimo, Enrico Giustiniano, Fulvio Nisi, Pierluigi Zulli, and Emiliano Agosteo.
2025. "MAPK, PI3K/Akt Pathways, and GSK-3β Activity in Severe Acute Heart Failure in Intensive Care Patients: An Updated Review" Journal of Cardiovascular Development and Disease 12, no. 7: 266.
https://doi.org/10.3390/jcdd12070266
APA Style
Meco, M., Giustiniano, E., Nisi, F., Zulli, P., & Agosteo, E.
(2025). MAPK, PI3K/Akt Pathways, and GSK-3β Activity in Severe Acute Heart Failure in Intensive Care Patients: An Updated Review. Journal of Cardiovascular Development and Disease, 12(7), 266.
https://doi.org/10.3390/jcdd12070266